Wuhan, China

Lina Qian

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Wuhan Ll Science and Technology Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lina Qian. Retrieved from https://idiyas.com/inventor/lina-qian-mv7tmtv5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lina Qian: Innovator in Fused Ring Compounds

Introduction

Lina Qian is a prominent inventor based in Wuhan, China. She has made significant contributions to the field of pharmaceuticals through her innovative work on fused ring compounds. Her research focuses on developing compounds with high therapeutic potential and minimal side effects.

Latest Patents

Lina Qian holds a patent for a fused ring compound and its applications. The patent describes a fused ring compound represented by a specific formula, along with various forms such as pharmaceutically acceptable salts, stereoisomers, and isotopes. This compound exhibits high P2X4 antagonistic activity, excellent selectivity, low toxicity, and remarkable metabolic stability. Her work in this area has the potential to lead to advancements in drug development.

Career Highlights

Lina Qian is associated with Wuhan Ll Science and Technology Development Co., Ltd. Her role in the company has allowed her to focus on research and development in the pharmaceutical sector. With her expertise, she has contributed to the advancement of innovative solutions in medicine.

Collaborations

[Section skipped due to space constraints.]

Conclusion

Lina Qian's work on fused ring compounds showcases her dedication to innovation in the pharmaceutical industry. Her contributions are paving the way for new therapeutic options that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…